Fig. 4 | Nature Communications

Fig. 4

From: A diversity-oriented rhodamine library for wide-spectrum bactericidal agents with low inducible resistance against resistant pathogens

Fig. 4

Time-dependent killing of pathogens by RD22 or RD53 compared to clinical antibiotics. MRSA (ATCC43300) challenged with a vancomycin, linezolid, tigecycline; b RD22; c RD53. VRE (ATCC51299) challenged with d vancomycin, linezolid, tigecycline, daptomycin; e RD22; f RD53. Polymyxin E-resistant Acinetobacter baumannii. challenged with g polymyxin E, tigecycline h RD22; i RD53. Pathogens were grown to early exponential phase and challenged with RD22/53 or clinical antibiotics. Data are representative of three independent experiments. Error bars indicate s.d.

Back to article page